Together, these results demonstrate that selective pharmacological blockade of EP4 signaling by E7046 was able to largely abolish PGE2-mediated pro-tumor myeloid cell differentiation and immunosuppressive activities. This evidence concerns the gene PTGER4 and neoplasm.